HDFC Life Insurance Company Ltd Analyst Rating
based on 33 analysts
81.82%
Buy
15.15%
Hold
3.03%
Sell
Based on 33 analysts offering long term price targets for HDFC Life Insurance Company Ltd. An average target of ₹806.15
Source: S&P Global Market Intelligence
HDFC Life Insurance Company Ltd Share analysis
HDFC Life Insurance Company Ltd price forecast by 33 analysts
Upside of29.28%
High
₹900
Target
₹806.15
Low
₹585
HDFC Life Insurance Company Ltd target price ₹806.15, a slight upside of 29.28% compared to current price of ₹623.8. According to 33 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
HDFC Life Insurance Company Ltd revenue growth forecast
Expected growth rate Q1, FY2026:13.06%
Forecast
Actual
Including amortisation and stock based compensations
HDFC Life Insurance Company Ltd EPS growth forecast
EPS estimate Q1, FY2026:44.81%
Forecast
Actual
Source: S&P Global Market Intelligence
HDFC Life Insurance Company Ltd Performance
Day's Low
Day's High
₹618.2Day's Price Range₹626.552 Week's Low
52 Week's High
₹511.452-Week Price Range₹761.2
| Returns % | |
| 1 Month Return | -7.54 % |
| 3 Month Return | -14.29 % |
| 1 Year Return | -3.21 % |
| Market Stats | |
| Previous Close | ₹623.55 |
| Open | ₹619.70 |
| Volume | 39.96L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹1,34,437.00Cr |
HDFC Life Insurance Company Ltd Key Statistics
| P/E Ratio | 77.46 |
| PEG Ratio | 66.2 |
| Market Cap | ₹1,34,437.00 Cr |
| P/B Ratio | 9.29 |
| EPS | 7.32 |
| Dividend Yield | 0.32 |
| Sector | Insurance |
| ROE | 11.55 |
HDFC Life Insurance Company Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹1,34,437.00 Cr | 0.24% | 0.98 | ₹1,574 Cr | ₹1,01,481 Cr | |
| BUY | ₹1,40,085.90 Cr | 8.21% | 0.98 | NA | NA | |
| BUY | ₹92,819.00 Cr | 6.93% | 0.53 | NA | NA | |
| BUY | ₹95,751.69 Cr | 6.23% | 0.98 | ₹850 Cr | ₹89,683 Cr | |
| BUY | ₹5,73,329.42 Cr | 0.68% | 0.99 | ₹40,915 Cr | ₹8,45,966 Cr |
HDFC Life Insurance Company Ltd Mutual Fund Holdings
About HDFC Life Insurance Company Ltd
The company also offers a range of popular brands such as Click2Protect, Smart Woman, Smart Kid, Saral Jeevan Bima and Super Income Plan. HDFC Life Insurance Company Ltd also provides additional services such as wealth management, estate planning and retirement planning.
Share Price: ₹623.80 per share as on 20 Dec, 2024 04:01 PM
Market Capitalisation: ₹1,34,437.00Cr as of today
Revenue: ₹28,776.43Cr as on September 2024 (Q3 24)
Net Profit: ₹435.18Cr as on September 2024 (Q3 24)
Listing date: 17 Nov, 2017
Chairperson Name: Deepak Parekh
| Organisation | HDFC Life Insurance Company Ltd |
| Headquarters | Mumbai |
| Industry | Insurance |
| E-voting on shares | Click here to vote |
Key events for HDFC Life Insurance Company Ltd
Citi Reiterates Buy Call on HDFC Life Insurance - 10 Dec, 2024
Citi has reaffirmed its Buy rating on HDFC Life Insurance, setting a target price of ₹820 per share. The company is well-positioned to benefit from evolving customer preferences for embedded protection products and is expanding its presence in Tier-II and Tier-III markets. HDFC Life's focus on deploying sales manpower and its diversified distribution channels support sustainable growth, with expected mid-to-high double-digit Value of New Business CAGR over the medium term.HDFC Life Insurance Faces Major Data Breach - 05 Dec, 2024
HDFC Life Insurance has confirmed a significant data breach affecting 1.6 crore customers, with sensitive information leaked on the Dark Web. The company is investigating the incident to assess risks and damage.HDFC Life Shares Volatile Amid Bancassurance Clarifications - 29 Nov, 2024
HDFC Life faced volatility as shares dropped nearly 6% due to regulatory rumors but later rose nearly 2% after clarifying the inaccuracies of those reports.HDFC Life Refutes Bancassurance Regulation Rumors - 28 Nov, 2024
HDFC Life Insurance Company refuted media reports about potential caps on bancassurance contributions, stating the information is speculative. Shares fell 3.40% amid concerns over regulatory changes.HDFC Life Cyberattack Leads to Data Theft - 27 Nov, 2024
HDFC Life Insurance reported a cyberattack resulting in the theft of confidential customer data. Cybercriminals accessed sensitive information and demanded extortion. The company has initiated an investigation and is taking steps to address the breach.HDFC Life Reports Data Breach Incident - 26 Nov, 2024
HDFC Life Insurance disclosed a data breach involving customer information, marking a significant cybersecurity concern. The company is conducting an investigation and has initiated security measures to protect customer interests.HDFC Life Faces Data Theft Amid Stake Acquisition - 25 Nov, 2024
HDFC Life Insurance Company Ltd experienced a data theft incident while ICICI Lombard acquired a 0.19% stake, positively impacting share prices. The company is investigating the breach and prioritizing customer data privacy.ICICI Lombard Acquires Stake in HDFC Life Insurance - 24 Nov, 2024
ICICI Lombard General Insurance announced the acquisition of a 0.19% equity stake in HDFC Life Insurance for ₹233 crore, indicating strategic interest in the life insurance sector.ICICI Lombard Acquires Stake in HDFC Life Insurance - 23 Nov, 2024
ICICI Lombard has acquired a 0.19% stake in HDFC Life Insurance for Rs 233 crore. This acquisition does not involve any related party links, highlighting a strategic investment in a leading life insurance provider in India.HDFC Life Shares Decline Amid Cautious Market Sentiment - 19 Nov, 2024
On November 19, 2024, HDFC Life Insurance shares dropped significantly, closing down 2.87% due to negative market sentiment and concerns over growth and margins.HDFC Life Insurance Ordered to Pay Claim - 18 Nov, 2024
The NCDRC directed HDFC Standard Life Insurance to pay a Rs 50 lakh death insurance claim with 9% interest to the deceased's wife, rejecting the company's argument regarding undisclosed medical conditions.HDFC Life Stock Rises, Market Cap Increases - 14 Nov, 2024
HDFC Life Insurance Company shares rose by 1.20% today, increasing the stock price to ₹693.30 and boosting market capitalization to approximately ₹1,49,235.72 crore.HDFC Life's Strategic Insights on Indian Market - 13 Nov, 2024
HDFC Life MD Vibha Padalkar emphasized the advantage of home-grown companies in understanding Indian consumers. She discussed potential acquisitions, including Exide Life, and supported 100% FDI in insurance, despite foreign investors' limited success.HDFC Life Reports Strong Premium Growth in October - 12 Nov, 2024
HDFC Life Insurance Company Ltd posted a 28% increase in October premiums and a 23% rise in total annualised premium equivalent, indicating robust growth.
Insights on HDFC Life Insurance Company Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up
Mutual Funds have increased holdings from 9.31% to 10.63% in Sep 2024 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 27.02K Cr → 28.77K Cr (in ₹), with an average increase of 6.1% per quarter
NO EFFECTAgainst Peers
In the last 3 years, SBI Life Insurance Company Ltd has given 24.2% return, outperforming this stock by 25.6%
- NO EFFECT
Against Peers
In the last 1 year, ICICI Prudential Life Insurance Company Ltd has given 27.4% return, outperforming this stock by 33.7%
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 26.63% to 25.63% in Sep 2024 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 50.37% to 50.34% in Sep 2024 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 478.97 Cr → 435.18 Cr (in ₹), with an average decrease of 9.1% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, HDFCLIFE stock has moved down by -8.2%
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 11.73% to 10.77% in Sep 2024 quarter
News
Factors Behind the Rise in Dr Reddys Share Price
Recently, Dr Reddys share price has gained significant attention. Over the last five days, its share price surged 7.6%. Dr Reddys Laboratories is gaining attention due to its strategic focus on long-term growth and emerging markets. Despite underperforming against the Nifty Pharma Index over the last 1-5 years, international brokerage firms have upgraded their price targets for the company. This upgrade indicates confidence in Dr Reddys ability to overcome near-term hurdles and leverage future growth opportunities. The stocks recent challenges stem from heavy dependence on gRevlimid, whose sales are expected to decline by FY26, and increased overheads linked to rising investments in R&D, biosimilar trials, and manufacturing upgrades. These investments have led to temporary pressure on profit margins. For instance, earnings before interest, tax, depreciation, and amortisation (EBITDA) margins are forecasted to remain slightly under the pressure through FY27. However, analysts project accelerated earnings growth starting FY28 as new revenue streams such as GLP-1 APIs, biosimilars, and injectables mature. Dr Reddys is expanding its manufacturing infrastructure, focusing on high-demand areas like peptide APIs and injectables. It is also poised to capitalise on low-competition injectable launches in the US and growth in emerging markets, including India and Canada. The Canadian semaglutide market, estimated at US $ 1-1.5 billion (bn), offers a significant opportunity post the 2026 patent expiry. The companys ability to transition from near-term challenges to medium and long-term growth is driving investor optimism. Strategic investments, new market opportunities, and innovative initiatives position Dr Reddys for sustained growth, contributing to its recent share price surge. In the past five days, Dr Reddys share price is up 6.9%. In the last month, it has rallied 12.5%. In 2024, so far it has rallied 15.5%. Additionally, it surged 20.6% in the last year. The stock touched its 52-week high of Rs 1,420.2 on 21 August 2024 and a 52-week low of Rs 1,094.9 on 21 December 2023.20 Dec, 2024 06:13 PMStock Market Crash: Nifty Stocks with Positive Returns This Week
Dr Reddys Laboratories was recently upgraded by Nomura, with a price target of ₹1,500 per share. Nomura believes concerns about the high contribution of Revlimid have already been priced in. In the first half of the 2024-25 fiscal year, a large part of the companys growth was driven by initiatives, including clinical trials for biosimilars. The brokerage highlighted that Dr. Reddys Laboratories has significantly increased investments in manufacturing infrastructure, with its capex more than doubling in FY25. Moreover, the potential upside from GLP-1 and biosimilars has not been fully accounted for in FY27 estimates.20 Dec, 2024 04:48 PMIndian Equity Indices End Week Lower: Key Gainers and Losers
The top gainers on the Nifty included Dr. Reddys Laboratories, which surged by 1.49 per cent.20 Dec, 2024 04:12 PMHDFC Life Insurance Company Ltd Financials
Index Inclusions
HDFC Life Insurance Company Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 50.34% | ||
| Foreign Institutions | 25.63% | ||
| Mutual Funds | 10.63% | 14.17 | |
| Retail Investors | 10.77% | ||
| Others | 2.65% | 34.98 |
HDFC Life Insurance Company Ltd Key Indicators
HDFC Life Insurance Company Ltd Valuation
HDFC Life Insurance Company Ltd in the last 5 years
Lowest (51.17x)
March 23, 2020
Industry (22.20x)
December 19, 2024
Today (77.46x)
December 19, 2024
Highest (131.62x)
October 5, 2021
HDFC Life Insurance Company Ltd Earnings and Dividends
HDFC Life Insurance Company Ltd Earnings Results
HDFC Life Insurance Company Ltd’s net profit jumped 15.07% since last year same period to ₹435.18Cr in the Q2 2024-2025. On a quarterly growth basis, HDFC Life Insurance Company Ltd has generated -9.14% fall in its net profits since last 3-months.
Read More about Earnings ResultsHDFC Life Insurance Company Ltd Dividends April,2024
In the quarter ending March 2024, HDFC Life Insurance Company Ltd has declared dividend of ₹2 - translating a dividend yield of 0.63%.
Read More about Dividends
HDFC Life Insurance Company Ltd Technicals Summary
Bearish
Neutral
Bullish
HDFC Life Insurance Company Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on HDFC Life Insurance Company Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy HDFC Life Insurance Company Ltd shares.
HDFC Life Insurance Company Ltd (HDFCLIFE) share price today is ₹623.8
HDFC Life Insurance Company Ltd is listed on NSE
HDFC Life Insurance Company Ltd is listed on BSE
- Today’s highest price of HDFC Life Insurance Company Ltd is ₹626.5.
- Today’s lowest price of HDFC Life Insurance Company Ltd is ₹618.2.
PE Ratio of HDFC Life Insurance Company Ltd is 77.46
PE ratio = HDFC Life Insurance Company Ltd Market price per share / HDFC Life Insurance Company Ltd Earnings per share
Today’s traded volume of HDFC Life Insurance Company Ltd(HDFCLIFE) is 39.96L.
Today’s market capitalisation of HDFC Life Insurance Company Ltd(HDFCLIFE) is ₹134437Cr.
| HDFC Life Insurance Company Ltd(HDFCLIFE | Price |
|---|---|
52 Week High | ₹761.2 |
52 Week Low | ₹511.4 |
HDFC Life Insurance Company Ltd(HDFCLIFE) share price is ₹623.8. It is down -18.05% from its 52 Week High price of ₹761.2
HDFC Life Insurance Company Ltd(HDFCLIFE) share price is ₹623.8. It is up 21.98% from its 52 Week Low price of ₹511.4
| HDFC Life Insurance Company Ltd(HDFCLIFE | Returns |
|---|---|
1 Day Returns | 0.25% |
1 Month Returns | -7.54% |
3 Month Returns | -14.29% |
1 Year Returns | -3.21% |